About Kurt Graves
Form D filings for i2O Therapeutics from 2022 to 2023 list Kurt Graves as chief executive officer and director.
Kurt Graves first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Kurt Graves in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kurt Graves works with at each company, as listed on that company's latest Form D.
i2O Therapeutics, Inc. · Form D, Oct 18, 2023
CG
Christopher Gagliardi
Director
AA
Anthony Aiudi
Director